Chinese healthcare trio premarket Hong Kong listings

Jonathan Breen

February 01, 2021 08:45 am

Mainland-based healthcare sector issuers SciClone Phamaceuticals (Holdings), New Horizon Health and Joinn Laboratories (China) kicked off pre-deal investor education for their Hong Kong IPOs on Monday.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

CITIC Securities Credit Suisse Equity IPOs UBS Equity China China International Capital Corp Hong Kong SAR Asia Greater China Morgan Stanley Northeast Asia Asia Pacific Emerging Markets Goldman Sachs

JB

Jonathan Breen

Equities editor GlobalCapital Asia